Immunosuppression Enhances Oncolytic Adenovirus Replication and Antitumor Efficacy in the Syrian Hamster Model
Open Access
- 1 October 2008
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 16 (10) , 1665-1673
- https://doi.org/10.1038/mt.2008.162
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Prostate Cancer Gene Therapy Clinical TrialsMolecular Therapy, 2007
- Phase II Trial of CHOP Chemotherapy Followed by Tositumomab/Iodine I-131 Tositumomab for Previously Untreated Follicular Non-Hodgkin's Lymphoma: Five-Year Follow-Up of Southwest Oncology Group Protocol S9911Journal of Clinical Oncology, 2006
- Efficacy of Severe Acute Respiratory Syndrome Vaccine Based on a Nonhuman Primate Adenovirus in the Presence of Immunity Against Human AdenovirusHuman Gene Therapy, 2006
- Immunosuppression promotes reovirus therapy of colorectal liver metastasesCancer Gene Therapy, 2006
- Effect of Adenovirus-Mediated Heat Shock Protein Expression and Oncolysis in Combination with Low-Dose Cyclophosphamide Treatment on Antitumor Immune ResponsesCancer Research, 2006
- Adenoviral Strategies for the Gene Therapy of CancerSeminars in Oncology, 2005
- Clinical Pharmacokinetics of CyclophosphamideClinical Pharmacokinetics, 2005
- Tolerance induction in clinical transplantationTransplant Immunology, 2004
- Intratumoral Spread of Wild-Type Adenovirus Is Limited After Local Injection of Human Xenograft Tumors: Virus Persists and Spreads Systemically at Late Time PointsHuman Gene Therapy, 2003
- Immune Transfer Protects Severely Immunosuppressed Mice from Murine Cytomegalovirus Retinitis and Reduces the Viral Load in Ocular TissueThe Journal of Infectious Diseases, 2000